EUVIMEDEUVIMED entdecken
Klinische Studie (Phase II)Multizentrische StudieOpen Access

Atezolizumab for Advanced Alveolar Soft Part Sarcoma

Alice P Chen, Elad Sharon, Geraldine O'Sullivan-Coyne, Nancy Moore, Jared C Foster, James S Hu, Brian A Van Tine, Anthony P Conley, William L Read, Richard F Riedel, Melissa A Burgess, John Glod und 19 weitere

New England Journal of Medicine · 07.09.2023 · 389 (10) · 911-921

DOI: 10.1056/nejmoa2303383 ↗

Kurz gefasst

Klinische Studie (Phase II) in der Zeitschrift New England Journal of Medicine, erschienen am 07.09.2023. Verfasst von Alice P Chen und 30 weiteren Autor:innen. Beteiligte Einrichtung: From the Division of Cancer Treatment and Diagnosis (A.P. Chen, E.S., G.O.-C., N.M., J.C.F., A.R.N., N.T., L.K.F., C.L.R., J.H.D.) and the Center for…. Hauptthemen laut MEDLINE: Antibodies, Monoclonal, Humanized, B7-H1 Antigen, Sarcoma, Alveolar Soft Part. Die Arbeit wurde bisher 172-mal zitiert (Crossref) und nennt 38 Literaturangaben. Der Volltext ist frei in PubMed Central verfügbar. Gefördert von: NCATS NIH HHS, NCI NIH HHS, Intramural NIH HHS.

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Kein Abstract verfügbar.

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

Antibodies, Monoclonal, HumanizedB7-H1 AntigenSarcoma, Alveolar Soft PartAdolescentAdultChildHumansInfant, NewbornBody WeightAdministration, Intravenous

Substanzen

Antibodies, Monoclonal, HumanizedatezolizumabB7-H1 Antigen

Autor:innen und Institutionen

  • From the Division of Cancer Treatment and Diagnosis (A.P. Chen, E.S., G.O.-C., N.M., J.C.F., A.R.N., N.T., L.K.F., C.L.R., J.H.D.) and the Center for Cancer Research (J.G., J.H.D.), National Cancer Institute, Bethesda,…

ORCID-Profile: Christina L Rosenberger

Förderung

  • NCATS NIH HHS
  • NCI NIH HHS
  • Intramural NIH HHS
  • National Cancer Institute
  • Genentech Inc.

Zitieren

APA

Chen, A. P., Sharon, E., O'Sullivan-Coyne, G., Moore, N., Foster, J. C., Hu, J. S., Van Tine, B. A., Conley, A. P., Read, W. L., Riedel, R. F., Burgess, M. A., Glod, J., Davis, E. J., Merriam, P., Naqash, A. R., Fino, K. K., Miller, B. L., Wilsker, D. F., Begum, A., …, & Doroshow, J. H. (2023). Atezolizumab for Advanced Alveolar Soft Part Sarcoma. New England Journal of Medicine, 389(10), 911-921. https://doi.org/10.1056/nejmoa2303383

Vancouver

Chen AP, Sharon E, O'Sullivan-Coyne G, Moore N, Foster JC, Hu JS, et al. Atezolizumab for Advanced Alveolar Soft Part Sarcoma. New England Journal of Medicine. 2023;389(10):911-921. doi:10.1056/nejmoa2303383

BibTeX
@article{Chen2023,
  author = {Chen, Alice P and Sharon, Elad and O'Sullivan-Coyne, Geraldine and Moore, Nancy and Foster, Jared C and Hu, James S and Van Tine, Brian A and Conley, Anthony P and Read, William L and Riedel, Richard F and Burgess, Melissa A and Glod, John and Davis, Elizabeth J and Merriam, Priscilla and Naqash, Abdul R and Fino, Kristin K and Miller, Brandon L and Wilsker, Deborah F and Begum, Asma and Ferry-Galow, Katherine V and Deshpande, Hari A and Schwartz, Gary K and Ladle, Brian H and Okuno, Scott H and Beck, Jill C and Chen, James L and Takebe, Naoko and Fogli, Laura K and Rosenberger, Christina L and Parchment, Ralph E and Doroshow, James H},
  title = {Atezolizumab for Advanced Alveolar Soft Part Sarcoma},
  journal = {New England Journal of Medicine},
  year = {2023},
  volume = {389},
  number = {10},
  pages = {911--921},
  doi = {10.1056/nejmoa2303383}
}
Kostenlos starten →